Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;114:894-904
Published online before print August 21, 2006, doi: 10.1161/CIRCULATIONAHA.105.609990
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
114/9/894    most recent
CIRCULATIONAHA.105.609990v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shaw, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shaw, L. J.
Related Collections
Right arrow Health policy and outcome research
Right arrow Chronic ischemic heart disease
Right arrowRelated Article

(Circulation. 2006;114:894-904.)
© 2006 American Heart Association, Inc.


Health Services and Outcomes Research

The Economic Burden of Angina in Women With Suspected Ischemic Heart Disease

Results From the National Institutes of Health–National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation

Leslee J. Shaw, PhD; C. Noel Bairey Merz, MD; Carl J. Pepine, MD; Steven E. Reis, MD; Vera Bittner, MD; Kevin E. Kip, PhD; Sheryl F. Kelsey, PhD; Marian Olson, MS; B. Delia Johnson, PhD; Sunil Mankad, MD; Barry L. Sharaf, MD; William J. Rogers, MD; Gerald M. Pohost, MD; George Sopko, MD, for the Women’s Ischemia Syndrome Evaluation (WISE) Investigators

From the Division of Cardiology, Department of Medicine, Cedars-Sinai Research Institute, Cedars-Sinai Medical Center, Los Angeles, Calif (L.J.S., C.N.B.M.); Division of Cardiology, Department of Medicine, University of Florida, Gainesville (C.J.P.); Cardiovascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pa (S.E.R.); Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pa (K.E.K., S.F.K., M.O., B.D.J.); Division of Cardiology, Department of Medicine, Allegheny University of the Health Sciences, Pittsburgh, Pa (S.M.); Division of Cardiology, Rhode Island Hospital, Providence, RI (B.L.S.); Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham (V.B., W.J.R.); Division of Cardiology, University of Southern California, Los Angeles (G.M.P.); and National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Md (G.S.).

Correspondence to Leslee J. Shaw, Emory University School of Medicine, Suite 1-North, 1256 Briarcliff Rd NE, Atlanta, GA 30306. E-mail leslee.shaw{at}emory.edu

Received December 30, 2005; revision received May 23, 2006; accepted June 22, 2006.

Background— Coronary angiography is one of the most frequently performed procedures in women; however, nonobstructive (ie, <50% stenosis) coronary artery disease (CAD) is frequently reported. Few data exist regarding the type and intensity of resource consumption in women with chest pain after coronary angiography.

Methods and Results— A total of 883 women referred for coronary angiography were prospectively enrolled in the National Institutes of Health–National Heart, Lung, and Blood Institute–sponsored Women’s Ischemia Syndrome Evaluation (WISE). Cardiovascular prognosis and cost data were collected. Direct (hospitalizations, office visits, procedures, and drug utilization) and indirect (out-of-pocket, lost productivity, and travel) costs were estimated through 5 years of follow-up. Among 883 women, 62%, 17%, 11%, and 10% had nonobstructive and 1-vessel, 2-vessel, and 3-vessel CAD, respectively. Five-year cardiovascular death or myocardial infarction rates ranged from 4% to 38% for women with nonobstructive to 3-vessel CAD (P<0.0001). Five-year rates of hospitalization for chest pain occurred in 20% of women with nonobstructive CAD, increasing to 38% to 55% for women with 1-vessel to 3-vessel CAD (P<0.0001). The volume of repeat catheterizations or angina hospitalizations was 1.8-fold higher in women with nonobstructive versus 1-vessel CAD after 1 year of follow-up (P<0.0001). Drug treatment was highest for those with nonobstructive or 1-vessel CAD (P<0.0001). The proportion of costs for anti-ischemic therapy was higher for women with nonobstructive CAD (15% versus 12% for 1-vessel to 3-vessel CAD; P=0.001). For women with nonobstructive CAD, average lifetime cost estimates were $767 288 (95% CI, $708 480 to $826 097) and ranged from $1 001 493 to $1 051 302 for women with 1-vessel to 3-vessel CAD (P=0.0003).

Conclusions— Symptom-driven care is costly even for women with nonobstructive CAD. Our lifetime estimates for costs of cardiovascular care identify a significant subset of women who are unaccounted for within current estimates of the economic burden of coronary heart disease.


 

CLINICAL PERSPECTIVE


Related Article:

Issue Highlights
Circulation 2006 114: 869. [Full Text]



This article has been cited by other articles:


Home page
CirculationHome page
L. J. Shaw, R. E. Shaw, C. N. B. Merz, R. G. Brindis, L. W. Klein, B. Nallamothu, P. S. Douglas, R. J. Krone, C. R. McKay, P. C. Block, et al.
Impact of Ethnicity and Gender Differences on Angiographic Coronary Artery Disease Prevalence and In-Hospital Mortality in the American College of Cardiology-National Cardiovascular Data Registry
Circulation, April 8, 2008; 117(14): 1787 - 1801.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
V. Bittner
Angina Pectoris: Reversal of the Gender Gap
Circulation, March 25, 2008; 117(12): 1505 - 1507.
[Full Text] [PDF]


Home page
CirculationHome page
W. Rosamond, K. Flegal, K. Furie, A. Go, K. Greenlund, N. Haase, S. M. Hailpern, M. Ho, V. Howard, B. Kissela, et al.
Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Circulation, January 29, 2008; 117(4): e25 - e146.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. P. Giugliano and E. Braunwald
The Year in Non ST-Segment Elevation Acute Coronary Syndrome
J. Am. Coll. Cardiol., October 2, 2007; 50(14): 1386 - 1395.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. D. Henry, C. L. Grines, M. W. Watkins, N. Dib, G. Barbeau, R. Moreadith, T. Andrasfay, and R. L. Engler
Effects of Ad5FGF-4 in Patients With Angina: An Analysis of Pooled Data From the AGENT-3 and AGENT-4 Trials
J. Am. Coll. Cardiol., September 11, 2007; 50(11): 1038 - 1046.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. Rosamond, K. Flegal, G. Friday, K. Furie, A. Go, K. Greenlund, N. Haase, M. Ho, V. Howard, B. Kissela, et al.
Heart Disease and Stroke Statistics--2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Circulation, February 6, 2007; 115(5): e69 - e171.
[Full Text] [PDF]


Home page
Journal Watch CardiologyHome page
Women with Ischemic Symptoms and Nonobstructive CAD
Journal Watch Cardiology, October 4, 2006; 2006(1004): 6 - 6.
[Full Text]